Claims for Patent: 5,876,722

Summary for Patent: 5,876,722

Title:	DNA encoding Derf II, the major mite allergen, host cells containing such DNA and methods for producing Derf II
Abstract:	The invention provides a DNA encoding at least one part of genetic information of protein which has biochemical and immunological properties of a major allergen of Dermatophagoides farinae (Derf II).
Inventor(s):	Yuuki; Toshifumi (Tokyo, JP), Okumura; Yasushi (Tokyo, JP), Yamakawa; Hiroshi (Urayasu, JP)
Assignee:	Asahi Breweries, Ltd. (Tokyo, JP) Torii & Co., Ltd. (Tokyo, JP)
Application Number:	08/910,075
Patent Claims:	1. An isolated DNA comprising a DNA segment encoding the major mite allergen Derf II of Dermatophagoides farinae, wherein said allergen has the amino acid sequence selected from the group consisting of amino acid residues 14-142 of SEQ ID NO: 2 and amino acid residues 14-142 of SEQ ID NO:4. 2. The isolated DNA of claim 1, wherein said DNA segment comprises a nucleic acid sequence selected from the group consisting of nucleotides 40-426 of SEQ ID NO:1 and nucleotides 40-426 of SEQ ID NO:3. 3. A replication vector comprising the nucleic acid sequence of the isolated DNA of claim 1 and at least one selective marker and at least one restriction site outside of said DNA segment. 4. A plasmid comprising the nucleic acid sequence of the isolated DNA of claim 1 and an expression cassette, wherein said cassette comprises said DNA segment. 5. A host cell of a species other than Dermatophagoides farinae, comprising the vector of claim 3. 6. The host cell of claim 5, wherein said host cell is a prokaryotic cell. 7. The host cell of claim 6, wherein said prokaryotic cell is Escherichia coli. 8. A replication vector comprising the nucleic acid sequence of the isolated DNA of claim 2 and at least one selective marker and at least one restriction site outside of said DNA segment. 9. A method for producing the Derf II allergen, comprising culturing a host cell of a species other than Dermatophagoides farinae, wherein said host cell comprises the vector of claim 8, under conditions to permit expression of the Derf II allergen encoded by said DNA segment. 10. In the method for the treatment of an allergic disease by means of desensitization therapy by administering to a subject gradually increasing doses of a causative agent, the improvement wherein said causative agent is the Derf II allergen expressed upon culturing of the host cell of claim 6, under conditions to permit expression of the Derf II allergen encoded by said DNA segment. 11. In the method for the treatment of an allergic disease by means of desensitization therapy by administering to a subject gradually increasing doses of a causative agent, the improvement wherein said causative agent is the Derf II allergen comprising amino acid residues 14-142 of SEQ ID NO:2 or amino acid residues 14-142 of SEQ ID NO:4.

Details for Patent 5,876,722

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Greer Laboratories, Inc.	N/A	insects (whole body), mite dermatophagoides farinae	Injection	101834	09/15/1958		2010-03-03